Middle East Pharmaceutical Industries Company (TADAWUL:4016)
59.80
-0.20 (-0.33%)
Jul 23, 2026, 3:11 PM AST
TADAWUL:4016 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 493.25 | 460.48 | 394 | 338.44 | 302.66 | 287.22 |
Revenue Growth | 18.70% | 16.87% | 16.42% | 11.82% | 5.38% | -4.79% |
Gross Profit Gross Profit Growth | 306.03 | 285.78 | 242.41 | 203.7 | 183.45 | 173.76 |
Operating Income Operating Income Growth | 115.18 | 106.93 | 89.29 | 77.53 | 69.41 | 76.16 |
Net Income Net Income Growth | 104.51 | 97.01 | 79.85 | 65.83 | 59.45 | 66.28 |
Earnings Per Share EPS Growth | 2.99 | 2.77 | 2.28 | 1.88 | 1.70 | 1.89 |
EPS Growth | 16.28% | 21.49% | 21.30% | 10.72% | -10.31% | -8.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Export Customers Export Customers Growth | 56.7 | 57.02 | 50.03 | 37.22 | 26.11 |
Public Customers Public Customers Growth | 100.89 | 93.43 | 75.68 | 55.91 | 68.58 |
Private Customers Private Customers Growth | 335.66 | 310.04 | 268.29 | 245.32 | 207.97 |
Total Total Growth | 493.25 | 460.48 | 394 | 338.44 | 302.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 18.82 | 34.37 | 22.65 | 15.11 | 23.79 | 19.04 |
Total Debt Total Debt Growth | 83.44 | 63.84 | 63.26 | 62 | 84.97 | 87.04 |
Net Cash (Debt) Net Cash Growth | -64.62 | -29.47 | -40.61 | -46.9 | -61.18 | -68 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.85 | -0.84 | -1.16 | -1.34 | -1.75 | -1.94 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 76.64 | 88.54 | 33.08 | 92.66 | 68.57 | 40.72 |
Capital Expenditures CapEx Growth | -23.31 | -14.79 | -11.17 | -20.83 | -9.58 | -15.43 |
Free Cash Flow Free Cash Flow Growth | 53.34 | 73.74 | 21.91 | 71.82 | 58.99 | 25.28 |
Free Cash Flow Growth | 272.56% | 236.62% | -69.50% | 21.76% | 133.30% | 121.46% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.04% | 62.06% | 61.52% | 60.19% | 60.61% | 60.50% |
Operating Margin | 23.35% | 23.22% | 22.66% | 22.91% | 22.93% | 26.52% |
Pretax Margin | 22.69% | 22.53% | 21.92% | 21.11% | 21.48% | 24.53% |
Profit Margin | 21.19% | 21.07% | 20.27% | 19.45% | 19.64% | 23.08% |
FCF Margin | 10.81% | 16.01% | 5.56% | 21.22% | 19.49% | 8.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 1.383 | 1.383 | 1.143 |
Dividend Per Share Growth | 21.00% | 21.00% | - |
Dividend Yield | 2.31% | 2.21% | 1.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.98 | 22.93 | 30.51 | - | - | - |
Forward PE | - | 20.16 | 24.86 | - | - | - |
P/FCF Ratio | 39.14 | 30.16 | 111.20 | - | - | - |
PS Ratio | 4.23 | 4.83 | 6.18 | - | - | - |